“It Saved My Life: Depression Treatment with rTMS Turns Lives Around” – new study finds… A new neural remedy called Stanford neuromodulation therapy is being used to treat people struggling with mental illness with promising results. In Stanford’s small study of people with severe depression that other treatments hadn’t helped, almost 80% of those who received the treatment went into remission, after five days of sessions.
Those are Stanford’s results, with Stanford’s own protocol, in that study’s patients. They aren’t BrainStim’s results, and they don’t predict what any one person will experience. The article describes how Stanford used imaging to target rTMS (repetitive Transcranial Magnetic Stimulation) more precisely.
You can read the full article in KQED: https://www.kqed.org/news/11898991/it-saved-my-life-depression-treatment-turns-lives-around-in-five-days
A couple of people who received treatment using this sophisticated targeting were quoted in the article:
After 45 years of depression and numerous failed attempts to medicate his illness, Tommy Van Brocklin, a civil engineer, says he didn’t see a way out. “The past couple of years I just started crying a lot,” he said. “I was just a real emotional wreck.”
So last September, Van Brocklin flew across the country from his home in Tennessee to Stanford, where he underwent the new rTMS treatment. Almost immediately he started feeling more optimistic and sleeping longer and deeper. “I wake up now and I want to come to work, whereas before I’d rather stick a sharp stick in my eye,” said Van Brocklin. “I have not had any depressed days since my treatment.”
He is hopeful the changes stick. More larger studies are needed to verify how long the new rTMS treatment will last.
At least for Emma, the woman who received Stanford’s treatment three years ago in a similar study, the results are holding. She says she still has ups and downs but “it’s an entirely different me dealing with it.”
She says the regimen rewired her from the inside out. “It saved my life, and I’ll be forever grateful,” said Emma, her voice cracking with emotion. “It saved my life.”
After 45 years of depression and numerous failed attempts to medicate his illness, Tommy Van Brocklin, a civil engineer, says he didn’t see a way out. “The past couple of years I just started crying a lot,” he said. “I was just a real emotional wreck.”
So last September, Van Brocklin flew across the country from his home in Tennessee to Stanford, where he underwent the new rTMS treatment. Almost immediately he started feeling more optimistic and sleeping longer and deeper. “I wake up now and I want to come to work, whereas before I’d rather stick a sharp stick in my eye,” said Van Brocklin. “I have not had any depressed days since my treatment.”
He is hopeful the changes stick. More larger studies are needed to verify how long the new rTMS treatment will last.
At least for Emma, the woman who received Stanford’s treatment three years ago in a similar study, the results are holding. She says she still has ups and downs but “it’s an entirely different me dealing with it.”
She says the regimen rewired her from the inside out. “It saved my life, and I’ll be forever grateful,” said Emma, her voice cracking with emotion. “It saved my life.”
These studies are bringing hope to non-invasive and drug-free rTMS treatments!
MeRT, which BrainStim offers, is a different protocol: it uses detailed diagnostics to plan where to treat. It isn’t the Stanford protocol, and the Stanford results above don’t apply to it. Read more about MeRT and our protocols for treatment.